Well into his second stint leading the US Food and Drug Administration, Robert Califf feels the country is in “serious jeopardy” with so many key ingredients for medical products coming from China — a problem, he said, that amounts to a matter of national security.
The commissioner, who spoke at a recent event hosted by the Alliance for a Stronger FDA, pointed to supply chain issues the US experienced during the pandemic which could prove problematic,